Top Markets
Coin of the day
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
Clasificación en acciones #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
Precio por acción
$0.66936954
Última sincronización: 2026-07-28
Capitalización bursátil
$89.04M
Cambio (1 día)
0.00%
Cambio (1 año)
-40.10%
País
TW
Comercio BRIM Biotechnology, Inc. (6885)

Categoría

Historial del precio de la acción de BRIM Biotechnology, Inc. (6885)
Precio más alto de cierre: $0.68 el 2026-07-01

Precio más bajo de cierre: $0.81 el 2022-06-01
Historial del precio de la acción de BRIM Biotechnology, Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -7.17%
2025 -13.55%
2024 -45.45%
2023 59.53%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH